Corroyer-Dulmont, A., Pérès, E. A., Petit, E., Guillamo, J., Varoqueaux, N., Roussel, S., . . . Valable, S. (2013). Detection of glioblastoma response to temozolomide combined with bevacizumab based on µMRI and µPET imaging reveals [(18)F]-fluoro-l-thymidine as an early and robust predictive marker for treatment efficacy. Oxford University Press.

Corroyer-Dulmont, Aurélien, et al. Detection of Glioblastoma Response to Temozolomide Combined With Bevacizumab Based On µMRI and µPET Imaging Reveals [(18)F]-fluoro-l-thymidine As an Early and Robust Predictive Marker for Treatment Efficacy. Oxford University Press, 2013.

Corroyer-Dulmont, Aurélien, et al. Detection of Glioblastoma Response to Temozolomide Combined With Bevacizumab Based On µMRI and µPET Imaging Reveals [(18)F]-fluoro-l-thymidine As an Early and Robust Predictive Marker for Treatment Efficacy. Oxford University Press, 2013.